They also found that a knockout of MyD88, the adaptor molecule shared by TLR9 and the IL-1β receptor IL-1R, is crucial for signaling that promotes NASH and fibrosis. This evidence concerns the gene MYD88 and metabolic dysfunction-associated steatohepatitis.